Clinical trial
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
NCT02673476 is registered in ClinicalTrials.gov with Alios Biopharma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
- Lead sponsor
- Alios Biopharma Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- October 31, 2016
- Enrollment
- 9 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.